BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Suiny (Anagliptin) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Suiny (Anagliptin)\, from ClinicalTrials.
 gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07442006-301@assetmemo.bio
DTSTAMP:20261121T005607Z
DTSTART;VALUE=DATE:20270331
DTEND;VALUE=DATE:20270401
SUMMARY:Suiny (Anagliptin): Phase 4 readout est. (NCT07442006)
DESCRIPTION:Suiny (Anagliptin)\, phase 4\, Type 2 Diabetes.\nStudy: Glycemi
 c Variability of Combination Therapies in T2DM\nEstimated primary completi
 on: 31 March 2027. This is a ClinicalTrials.gov estimate\, not a confirmed
  readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/an
 agliptin#upcoming-events\nRegistry record: https://clinicaltrials.gov/stud
 y/NCT07442006
URL:https://assetmemo.bio/drug/anagliptin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
